A safer drug supply The FDA was pretty clear in their December 19, 2024 letter when they wrote: Although compounded drug products can provide treatment options for patients during a drug shortage, compounded drugs have not undergone FDA premarket review for safety, effectiveness, and quality, and lack a premarket inspection and finding of manufacturing quality that is part of the drug approval process
However, if initial verdicts result in substantial plaintiff awards, manufacturers may calculate that settling thousands of claims proves less expensive than facing repeated trials with unpredictable outcomes
Trustpilot: Generally high ratings, with most reviewers saying the program works for them
Personalized dosing GLP-1 dosing is tailored to your unique response
The effects are not temporary, as fat cells expand naturally as you ingest food
Instructions Inform patients of the potential risks and benefits of semaglutide and of alternative modes of therapy